Literature DB >> 16718780

T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics.

Jie-Ting Tang1, Jing-Yuan Fang, Wei-Qi Gu, En-Lin Li.   

Abstract

AIM: To explore the relationship among interferon-gamma (IFN-gamma) activity, fibrogenesis, T cell immune responses and hepatic inflammatory activity.
METHODS: Peripheral blood samples from a total of 43 hepatitis B cirrhotic patients (LC) and 19 healthy controls (NC) were collected to measure their serum levels of IFN-gamma, interleukin-2 (IL-2), soluble interleukin-2 receptor (sIL-2R), interleukin-10 (IL-10) and three serological markers of fibrosis including hyaluronic acid (HA), procollagen type III peptide (PIIIP), and type IV collagen were measured using a double antibody sandwich ELISA. Also, serum total bilirubin (TB) and alanine aminotransferase (ALT) were measured by routine measures.
RESULTS: The concentrations of serological markers of fibrosis in patients with active cirrhosis (ALC) were significantly higher than those in stationary liver cirrhosis (SLC) or NC groups. The levels of serological markers in HBeAg-positive patients were significantly higher than those in HBeAg-negative patients. In SLC and ALC patients, a negative linear correlation was found between IFN-gamma levels and the serological markers of fibrosis. IFN-gamma and IL-2 levels in the ALC group were significantly higher than those in the SLC and NC groups, but the statistical difference was not significant between the latter two. In contrast, IL-10 levels in the SLC group were significantly higher than that in the NC group, but no significant difference was found between SLC and ALC groups. The sIL-2R level was elevated gradually in all these groups, and the differences were significant. Positive linear correlations were seen between IFN-gamma activity and ALT levels (r = 0.339, P < 0.05), and IL-2 activity and TB levels (r = 0.517, P < 0.05). sIL-2R expression was positively correlated with both ALT and TB levels (r = 0.324, 0.455, P < 0.05), whereas there was no statistically significant correlation between IL-10 expression and serum ALT and TB levels (r = -0.102, -0.093, P > 0.05). Finally, there was a positive correlation between IFN-gamma and IL-2 levels.
CONCLUSION: T cell immune responses are correlated with fibrosis and hepatic inflammatory activity and may play an important role in liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718780      PMCID: PMC4124374          DOI: 10.3748/wjg.v12.i19.3015

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo.

Authors:  I Sakaida; K Uchida; Y Matsumura; K Okita
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

2.  Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.

Authors:  G S Baroni; L D'Ambrosio; P Curto; A Casini; R Mancini; A M Jezequel; A Benedetti
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Implication of inflammation-related cytokines in the natural history of liver cirrhosis.

Authors:  José A Girón-González; Carmen Martínez-Sierra; Claudio Rodriguez-Ramos; Manuel A Macías; Paloma Rendón; Fernando Díaz; Clotilde Fernández-Gutiérrez; Leopoldo Martín-Herrera
Journal:  Liver Int       Date:  2004-10       Impact factor: 5.828

4.  [Th1-cytokines in chronic hepatitis B and C].

Authors:  L S Priĭmiagi; V T Tefanova; T G Tallo; E V Shmidt; O V Solomonova; T P Tuĭsk; G V Kikosh; L M Krupskaia; S A Lisitsyna
Journal:  Vopr Virusol       Date:  2002 May-Jun

5.  Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.

Authors:  Tadashi Tsukamoto; Takatsugu Yamamoto; Takashi Ikebe; Shigekazu Takemura; Taichi Shuto; Shoji Kubo; Kazuhiro Hirohashi; Hiroaki Kinoshita
Journal:  Hepatogastroenterology       Date:  2004 May-Jun

6.  Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection.

Authors:  N Hyodo; I Nakamura; M Imawari
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.

Authors:  M Chevallier; S Guerret; P Chossegros; F Gerard; J A Grimaud
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

8.  Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.

Authors:  Y Sawayama; J Hayashi; Y Kawakami; N Furusyo; I Ariyama; Y Kishihara; K Ueno; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 9.  Modulation of liver injury by interleukin-10.

Authors:  H Louis; O Le Moine; M Goldman; J Devière
Journal:  Acta Gastroenterol Belg       Date:  2003 Jan-Mar       Impact factor: 1.316

10.  Expression of Th1 and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients.

Authors:  M Lee; M Lee; S K Lee; M Son; S W Cho; S Park; H I Kim
Journal:  J Korean Med Sci       Date:  1999-04       Impact factor: 2.153

View more
  5 in total

Review 1.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.

Authors:  Jarmila Porubcová; Emília Dvoroznáková; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

3.  Myofibroblasts and their resistance to apoptosis: a possible mechanism of osteoradionecrosis.

Authors:  Lei Tian; Li-Sheng He; Bhavesh Soni; Hong-Tao Shang
Journal:  Clin Cosmet Investig Dent       Date:  2012-07-13

4.  Circulating cytokines and histological liver damage in chronic hepatitis B infection.

Authors:  Kittiyod Poovorawan; Pisit Tangkijvanich; Chintana Chirathaworn; Naruemon Wisedopas; Sombat Treeprasertsuk; Piyawat Komolmit; Yong Poovorawan
Journal:  Hepat Res Treat       Date:  2013-10-31

Review 5.  Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies.

Authors:  Olga Hilda Orasan; George Ciulei; Angela Cozma; Madalina Sava; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2016-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.